Protein-Observed Fluorine NMR: A Bioorthogonal Approach for Small Molecule Discovery

Journal of Medicinal Chemistry

Volumn 59, Issue 11, 2016, Pages 5158-5171

  Arntson, Keith E ^a   Pomerantz, William C K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINO ACID; LIGAND; PROTEIN; FLUORINE; MOLECULAR LIBRARY;

AMINO ACID METABOLISM; BIOCHEMISTRY; FLUORINE NUCLEAR MAGNETIC RESONANCE; LIGAND BINDING; MEDICINAL CHEMISTRY; MOLECULAR INTERACTION; PROTEIN PROTEIN INTERACTION; REVIEW; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DEVELOPMENT; HUMAN; MOLECULAR LIBRARY; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE; PHARMACOLOGY;

DRUG DISCOVERY; FLUORINE; HUMANS; LIGANDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEINS; SMALL MOLECULE LIBRARIES;

EID: 84974626866     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/acs.jmedchem.5b01447     Document Type: Review

References (109)

1. Dunitz, J. D. Organic fluorine: odd man out ChemBioChem 2004, 5, 614-621 10.1002/cbic.200300801
2. Lemal, D. M. Perspective on fluorocarbon chemistry J. Org. Chem. 2004, 69, 1-11 10.1021/jo0302556
3. Emsley, J. Nature's Building Blocks: An A-Z Guide to the Elements; Oxford University Press: New York, 2001.
4. Chan, K. K. J.; O'Hagan, D. In Natural Product Biosynthesis by Microorganisms and Plants. Part B; Hopwood, D. A., Ed.; Elsevier Academic Press Inc.: San Diego, CA, 2012; Vol. 516, pp 219-235.
5. Som, P.; Atkins, H. L.; Bandoypadhyay, D.; Fowler, J. S.; Macgregor, R. R.; Matsui, K.; Oster, Z. H.; Sacker, D. F.; Shiue, C. Y.; Turner, H.; Wan, C. N.; Wolf, A. P.; Zabinski, S. V. A fluorinated glucose analog, 2-fluorodeoxy-D-glucose (F-18)-nontoxic tracer for rapid tumor detection J. Nucl. Med. 1980, 21, 670-675
6. Ahrens, E. T.; Zhong, J. In vivo MRI cell tracking using perfluorocarbon probes and fluorine-19 detection NMR Biomed. 2013, 26, 860-871 10.1002/nbm.2948
7. Ruiz-Cabello, J.; Barnett, B. P.; Bottomley, P. A.; Bulte, J. W. M. Fluorine (F-19) MRS and MRI in biomedicine NMR Biomed. 2011, 24, 114-129 10.1002/nbm.1570
8. Mignion, L.; Magat, J.; Schakman, O.; Marbaix, E.; Gallez, B.; Jordan, B. F. Hexafluorobenzene in comparison with perfluoro-15-crown-5-ether for repeated monitoring of oxygenation using 19F MRI in a mouse model Magn. Reson. Med. 2013, 69, 248-254 10.1002/mrm.24245
9. Dalvit, C. Ligand- and substrate-based F-19 NMR screening: Principles and applications to drug discovery Prog. Nucl. Magn. Reson. Spectrosc. 2007, 51, 243-I 10.1016/j.pnmrs.2007.07.002
10. Spotswood, T.; Evans, J. M.; Richards, J. H. Enzyme - substrate interaction by nuclear magnetic resonance J. Am. Chem. Soc. 1967, 89, 5052-5054 10.1021/ja00995a047
11. Hull, W. E.; Sykes, B. D. Fluorotyrosine alkaline-phosphatase- F-19 nuclear magnetic resonance relaxation times and molecular motion of individual fluorotyrosines Biochemistry 1974, 13, 3431-3437 10.1021/bi00714a002
12. Ge, X.; MacRaild, C. A.; Devine, S. M.; Debono, C. O.; Wang, G.; Scammells, P. J.; Scanlon, M. J.; Anders, R. F.; Foley, M.; Norton, R. S. Ligand-induced conformational change of Plasmodium falciparum AMA1 detected using F-19 NMR J. Med. Chem. 2014, 57, 6419-6427 10.1021/jm500390g
13. Leung, E. W. W.; Yagi, H.; Harjani, J. R.; Mulcair, M. D.; Scanlon, M. J.; Baell, J. B.; Norton, R. S. F-19 NMR as a probe of ligand interactions with the iNOS binding site of SPRY domain-containing SOCS box protein 2 Chem. Biol. Drug Des. 2014, 84, 616-625 10.1111/cbdd.12355
14. Gee, C. T.; Koleski, E. J.; Pomerantz, W. C. K. Fragment screening and druggability assessment for the CBP/p300 KIX domain through protein-observed 19F NMR spectroscopy Angew. Chem., Int. Ed. 2015, 54, 3735-3739 10.1002/anie.201411658
15. Mishra, N. K.; Urick, A. K.; Ember, S. W. J.; Schoenbrunn, E.; Pomerantz, W. C. Fluorinated aromatic amino acids are sensitive F-19 NMR probes for bromodomain-ligand interactions ACS Chem. Biol. 2014, 9, 2755-2760 10.1021/cb5007344
16. Pomerantz, W. C.; Wang, N.; Lipinski, A. K.; Wang, R.; Cierpicki, T.; Mapp, A. K. Profiling the dynamic interfaces of fluorinated transcription complexes for ligand discovery and characterization ACS Chem. Biol. 2012, 7, 1345-1350 10.1021/cb3002733
17. Urick, A. K.; Hawk, L. M. L.; Cassel, M. K.; Mishra, N. K.; Liu, S.; Adhikari, N.; Zhang, W.; dos Santos, C. O.; Hall, J. L.; Pomerantz, W. C. K. Dual screening of BPTF and Brd4 using protein-observed fluorine NMR uncovers new bromodomain probe molecules ACS Chem. Biol. 2015, 10, 2246-2256 10.1021/acschembio.5b00483
18. Dalvit, C.; Mongelli, N.; Papeo, G.; Giordano, P.; Veronesi, M.; Moskau, D.; Kummerle, R. Sensitivity improvement in F-19 NMR-based screening experiments: Theoretical considerations and experimental applications J. Am. Chem. Soc. 2005, 127, 13380-13385 10.1021/ja0542385
19. Stockman, B. J.; Dalvit, C. NMR screening techniques in drug discovery and drug design Prog. Nucl. Magn. Reson. Spectrosc. 2002, 41, 187-231 10.1016/S0079-6565(02)00049-3
20. O'Hagan, D.; Rzepa, H. S. Some influences of fluorine in bioorganic chemistry Chem. Commun. 1997, 645-652 10.1039/a604140j
21. Muller, K.; Faeh, C.; Diederich, F. Fluorine in pharmaceuticals: Looking beyond intuition Science 2007, 317, 1881-1886 10.1126/science.1131943
22. Wang, J.; Sanchez-Rosello, M.; Acena, J. L.; del Pozo, C.; Sorochinsky, A. E.; Fustero, S.; Soloshonok, V. A.; Liu, H. Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001-2011) Chem. Rev. 2014, 114, 2432-2506 10.1021/cr4002879
23. Schweizer, E.; Hoffmann-Roder, A.; Scharer, K.; Olsen, J. A.; Fah, C.; Seiler, P.; Obst-Sander, U.; Wagner, B.; Kansy, M.; Diederich, F. A fluorine scan at the catalytic center of thrombin: C-F, C-OH, and C-OMe bioisosterism and fluorine effects on pK(a) and log(D) values ChemMedChem 2006, 1, 611-621 10.1002/cmdc.200600015
24. Olsen, J. A.; Banner, D. W.; Seiler, P.; Sander, U. O.; D'Arcy, A.; Stihle, M.; Muller, K.; Diederich, F. A fluorine scan of thrombin inhibitors to map the fluorophilicity/fluorophobicity of an enzyme active site: Evidence for C-F center dot center dot center dot C=O interactions Angew. Chem., Int. Ed. 2003, 42, 2507-2511 10.1002/anie.200351268
25. Gerebtzoff, G.; Li-Blatter, X.; Fischer, H.; Frentzel, A.; Seelig, A. Halogenation of drugs enhances membrane binding and permeation ChemBioChem 2004, 5, 676-684 10.1002/cbic.200400017
26. Gerig, J. T. Fluorine NMR. http://www.biophysics.org/Portals/1/PDFs/Education/gerig.pdf.
27. Dalvit, C.; Ko, S. Y.; Vulpetti, A. Application of the rule of shielding in the design of novel fluorinated structural motifs and peptidomimetics J. Fluorine Chem. 2013, 152, 129-135 10.1016/j.jfluchem.2013.01.017
28. Vulpetti, A.; Dalvit, C. Design and generation of highly diverse fluorinated fragment libraries and their efficient screening with improved F-19 NMR methodology ChemMedChem 2013, 8, 2057-2069 10.1002/cmdc.201300351
29. Cellitti, S. E.; Jones, D. H.; Lagpacan, L.; Hao, X.; Zhang, Q.; Hu, H.; Brittain, S. M.; Brinker, A.; Caldwell, J.; Bursulaya, B.; Spraggon, G.; Brock, A.; Ryu, Y.; Uno, T.; Schultz, P. G.; Geierstanger, B. H. In vivo incorporation of unnatural amino acids to probe structure, dynamics, and ligand binding in a large protein by nuclear magnetic resonance spectroscopy J. Am. Chem. Soc. 2008, 130, 9268-9281 10.1021/ja801602q
30. Lian, C. Y.; Le, H. B.; Montez, B.; Patterson, J.; Harrell, S.; Laws, D.; Matsumura, I.; Pearson, J.; Oldfield, E. F-19 nuclear magnetic resonance spectroscopic study of fluorophenylalanine-labeled and fluorotryptophan-labeled avian egg-white lysozymes Biochemistry 1994, 33, 5238-5245 10.1021/bi00183a029
31. Pearson, J. G.; Oldfield, E.; Lee, F. S.; Warshel, A. Chemical shifts in proteins- A shielding trajectory analysis of the fluorine nuclear magnetic resonance spectrum of the Eschericia coli galactose binding-protein using a multipole shielding polarizability local reaction field moelcular dyanmics approach J. Am. Chem. Soc. 1993, 115, 6851-6862 10.1021/ja00068a049
32. Lau, E. Y.; Gerig, J. T. Origins of fluorine NMR chemical shifts in fluorine-containing proteins J. Am. Chem. Soc. 2000, 122, 4408-4417 10.1021/ja992107w
33. Dalvit, C.; Vulpetti, A. Fluorine-protein interactions and F-19 NMR isotropic chemical shifts: An empirical correlation with implications for drug design ChemMedChem 2011, 6, 104-114 10.1002/cmdc.201000412
34. Kitevski-LeBlanc, J. L.; Prosser, R. S. Current applications of F-19 NMR to studies of protein structure and dynamics Prog. Nucl. Magn. Reson. Spectrosc. 2012, 62, 1-33 10.1016/j.pnmrs.2011.06.003
35. Danielson, M. A.; Falke, J. J. Use of F-19 NMR to probe protein structure and conformational changes Annu. Rev. Biophys. Biomol. Struct. 1996, 25, 163-195 10.1146/annurev.bb.25.060196.001115
36. Wagner, G.; Wuthrich, K. Observation of internal motility of proteins by nuclear magnetic resonance in solution Methods Enzymol. 1986, 131, 307-326 10.1016/0076-6879(86)31047-4
37. Hull, W. E.; Sykes, B. D. Fluorotyrosine alkaline phosphatase internal mobility of individual tyrosines and role of chemical shift anisotropy as a F-19 nuclear spin relaxation mechanism in proteins J. Mol. Biol. 1975, 98, 121-153 10.1016/S0022-2836(75)80105-7
38. Hoeltzli, S. D.; Frieden, C. Stopped-flow NMR spectroscopy-real time unfolding studies of 6-F-19-tryptophan-labeled Eschericia Coli dihydrofolate reductase Proc. Natl. Acad. Sci. U. S. A. 1995, 92, 9318-9322 10.1073/pnas.92.20.9318
39. Ho, C.; Pratt, E. A.; Rule, G. S. Membrance-bound D-lactate dehydrogenase of Eschericia coli. A model for protein interactions in membranes Biochim. Biophys. Acta, Rev. Biomembr. 1989, 988, 173-184 10.1016/0304-4157(89)90018-X
40. Li, C. G.; Wang, G. F.; Wang, Y. Q.; Creager-Allen, R.; Lutz, E. A.; Scronce, H.; Slade, K. M.; Ruf, R. A. S.; Mehl, R. A.; Pielak, G. J. Protein F-19 NMR in Escherichia coli J. Am. Chem. Soc. 2010, 132, 321-327 10.1021/ja907966n
41. Loewen, M. C.; Klein-Seetharaman, J.; Getmanova, E. V.; Reeves, P. J.; Schwalbe, H.; Khorana, H. G. Solution F-19 nuclear Overhauser effects in structural studies of the cytoplasmic domain of mammalian rhodopsin Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 4888-4892 10.1073/pnas.051633098
42. Liu, J. J.; Horst, R.; Katritch, V.; Stevens, R. C.; Wuthrich, K. Biased signaling pathways in beta(2)-adrenergic receptor characterized by F-19-NMR Science 2012, 335, 1106-1110 10.1126/science.1215802
43. Kim, T. H.; Chung, K. Y.; Manglik, A.; Hansen, A. L.; Dror, R. O.; Mildorf, T. J.; Shaw, D. E.; Kobilka, B. K.; Prosser, R. S. The role of ligands on the equilibria between functional states of a G protein-coupled receptor J. Am. Chem. Soc. 2013, 135, 9465-9474 10.1021/ja404305k
44. Duewel, H.; Daub, E.; Robinson, V.; Honek, J. F. Incorporation of trifluoromethionine into a phage lysozyme: Implications and a new marker for use in protein F-19 NMR Biochemistry 1997, 36, 3404-3416 10.1021/bi9617973
45. Suzuki, Y.; Brender, J. R.; Soper, M. T.; Krishnamoorthy, J.; Zhou, Y. L.; Ruotolo, B. T.; Kotov, N. A.; Ramamoorthy, A.; Marsh, E. N. G. Resolution of oligomeric species during the aggregation of A beta(1-40) using F-19 NMR Biochemistry 2013, 52, 1903-1912 10.1021/bi400027y
46. Hammill, J. T.; Miyake-Stoner, S.; Hazen, J. L.; Jackson, J. C.; Mehl, R. A. Preparation of site-specifically labeled fluorinated proteins for F-19-NMR structural characterization Nat. Protoc. 2007, 2, 2601-2607 10.1038/nprot.2007.379
47. Ye, L. B.; Larda, S. T.; Li, Y. F.; Manglik, A.; Prosser, R. S. A comparison of chemical shift sensitivity of trifluoromethyl tags: optimizing resolution in F-19 NMR studies of proteins J. Biomol. NMR 2015, 62, 97-103 10.1007/s10858-015-9922-y
48. Frieden, C.; Hoeltzli, S. D.; Bann, J. G. The preparation of F-19-labeled proteins for NMR studies Methods Enzymol. 2004, 380, 400-415 10.1016/S0076-6879(04)80018-1
49. Pomerantz, W. C.; Wang, N. K.; Lipinski, A. K.; Wang, E. W.; Cierpicki, T.; Mapp, A. K. Profiling the dynamic interfaces of fluorinated transcriptional complexes for ligand discovery and characterization ACS Chem. Biol. 2012, 7, 1345-1350 10.1021/cb3002733
50. Shu, Q.; Frieden, C. Urea-dependent unfolding of murine adenosine deaminase: Sequential destabilization as measured by F-19 NMR Biochemistry 2004, 43, 1432-1439 10.1021/bi035651x
51. van Hest, J. C. M.; Kiick, K. L.; Tirrell, D. A. Efficient incorporation of unsaturated methionine analogues into proteins in vivo J. Am. Chem. Soc. 2000, 122, 1282-1288 10.1021/ja992749j
52. Tang, Y.; Tirrell, D. A. Biosynthesis of a highly stable coiled-coil protein containing hexafluoroleucine in an engineered bacterial host J. Am. Chem. Soc. 2001, 123, 11089-11090 10.1021/ja016652k
53. Kim, H. W.; Perez, J. A.; Ferguson, S. J.; Campbell, I. D. The specific incorporation of labeled aromatic amino acids into proteins through growth of bacteria in the presence of glyphosate-application to fluorotryptophan labeling to the H+-ATPase of Eschericia coli and NMR studies FEBS Lett. 1990, 272, 34-36 10.1016/0014-5793(90)80442-L
54. Steinrucken, H. C.; Amrhein, N. The herbicide glyphosate is a potent inhibitor of 5-enolpyruvyl shikimic acid 3-phopshate synthase Biochem. Biophys. Res. Commun. 1980, 94, 1207-1212 10.1016/0006-291X(80)90547-1
55. Leone, M.; Rodriguez-Mias, R. A.; Pellecchia, M. Selective incorporation of F-19-labeled Trp side chains for NMR-spectroscopy-based ligand-protein interaction studies ChemBioChem 2003, 4, 649-650 10.1002/cbic.200300597
56. Crowley, P. B.; Kyne, C.; Monteith, W. B. Simple and inexpensive incorporation of F-19-Tryptophan for protein NMR spectroscopy Chem. Commun. 2012, 48, 10681-10683 10.1039/c2cc35347d
57. Bogan, A. A.; Thorn, K. S. Anatomy of hot spots in protein interfaces J. Mol. Biol. 1998, 280, 1-9 10.1006/jmbi.1998.1843
58. Watkins, A. M.; Arora, P. S. Anatomy of beta-strands at protein-protein interfaces ACS Chem. Biol. 2014, 9, 1747-1754 10.1021/cb500241y
59. Bullock, B. N.; Jochim, A. L.; Arora, P. S. Assessing helical protein interfaces for inhibitor design J. Am. Chem. Soc. 2011, 133, 14220-14223 10.1021/ja206074j
60. Gavenonis, J.; Sheneman, B. A.; Siegert, T. R.; Eshelman, M. R.; Kritzer, J. A. Comprehensive analysis of loops at protein-protein interfaces for macrocycle design Nat. Chem. Biol. 2014, 10, 716-722 10.1038/nchembio.1580
61. Nelson, D. L.; Cox, M. M., Eds. Lehninger Principles of Biochemsitry, 5 th ed.; Freeman: New York, 2008.
62. Curtis-Marof, R.; Doko, D.; Rowe, M. L.; Richards, K. L.; Williamson, R. A.; Howard, M. J. F-19 NMR spectroscopy monitors ligand binding to recombinantly fluorine-labelled b'x from human protein disulphide isomerase (hPDI) Org. Biomol. Chem. 2014, 12, 3808-3812 10.1039/c4ob00699b
63. Wang, L.; Brock, A.; Herberich, B.; Schultz, P. G. Expanding the genetic code of Escherichia coli Science 2001, 292, 498-500 10.1126/science.1060077
64. Loscha, K. V.; Herlt, A. J.; Qi, R. H.; Huber, T.; Ozawa, K.; Otting, G. Multiple-site labeling of proteins with unnatural amino acids Angew. Chem., Int. Ed. 2012, 51, 2243-2246 10.1002/anie.201108275
65. Bann, J. G.; Frieden, C. Folding and domain-domain interactions of the chaperone PapD measured by F-19 NMR Biochemistry 2004, 43, 13775-13786 10.1021/bi048614u
66. Minnihan, E. C.; Young, D. D.; Schultz, P. G.; Stubbe, J. Incorporation of fluorotyrosines into ribonucleotide reductase using an evolved, polyspecific aminoacyl-tRNA synthetase J. Am. Chem. Soc. 2011, 133, 15942-15945 10.1021/ja207719f
67. Popot, J. L.; Engelman, D. M. Helical membrane protein folding, stability, and evolution Annu. Rev. Biochem. 2000, 69, 881-922 10.1146/annurev.biochem.69.1.881
68. Manglik, A.; Kim, T. H.; Masureel, M.; Altenbach, C.; Yang, Z.; Hilger, D.; Lerch, M. T.; Kobilka, T. S.; Thian, F. S.; Hubbell, W. L.; Prosser, R. S.; Kobilka, B. K. Structural insights into the dynamic process of beta(2)-adrenergic receptor signaling Cell 2015, 161, 1101-1111 10.1016/j.cell.2015.04.043
69. Ikura, M.; Kay, L. E.; Bax, A. A novel approach for sequential assignment of H-1, C-13, and N-15 spectra of larger proteins-heteronuclear triple resonance 3-dimensional NMR spectroscopy application to calmodulin Biochemistry 1990, 29, 4659-4667 10.1021/bi00471a022
70. Kitevski-LeBlanc, J. L.; Al-Abdul-Wahid, M. S.; Prosser, R. S. A mutagenesis-free approach to assignment of F-19 NMR resonances in biosynthetically labeled proteins J. Am. Chem. Soc. 2009, 131, 2054-2055 10.1021/ja8085752
71. Kitevski-LeBlanc, J. L.; Evanics, F.; Prosser, R. S. Approaches to the assignment of F-19 resonances from 3-fluorophenylalanine labeled calmodulin using solution state NMR J. Biomol. NMR 2010, 47, 113-123 10.1007/s10858-010-9415-y
72. Anderluh, G.; Razpotnik, A.; Podlesek, Z.; Macek, P.; Separovic, F.; Norton, R. S. Interaction of the eukaryotic pore-forming cytolysin equinatoxin II with model membranes: F-19 NMR studies J. Mol. Biol. 2005, 347, 27-39 10.1016/j.jmb.2004.12.058
73. Drake, S. K.; Bourret, R. B.; Luck, L. A.; Simon, M. I.; Falke, J. J. Activation of the phosphosignaling protein Chey. 1. Analysis of the phosphorylated conformation by F-19 NMR and protien engineering J. Biol. Chem. 1993, 268, 13081-13088
74. Evanics, F.; Kitevski, J. L.; Bezsonova, I.; Forman-Kay, J.; Prosser, R. S. F-19 NMR studies of solvent exposure and peptide binding to an SH3 domain Biochim. Biophys. Acta, Gen. Subj. 2007, 1770, 221-230 10.1016/j.bbagen.2006.10.017
75. Li, H.; Frieden, C. NMR studies of 4-F-19-phenylalanine-labeled intestinal fatty acid binding protein: Evidence for conformational heterogeneity in the native state Biochemistry 2005, 44, 2369-2377 10.1021/bi047600l
76. Shuker, S. B.; Hajduk, P. J.; Meadows, R. P.; Fesik, S. W. Discovering high-affinity ligands for proteins: SAR by NMR Science 1996, 274, 1531-1534 10.1126/science.274.5292.1531
77. Pellecchia, M.; Bertini, I.; Cowburn, D.; Dalvit, C.; Giralt, E.; Jahnke, W.; James, T. L.; Homans, S. W.; Kessler, H.; Luchinat, C.; Meyer, B.; Oschkinat, H.; Peng, J.; Schwalbe, H.; Siegal, G. Perspectives on NMR in drug discovery: a technique comes of age Nat. Rev. Drug Discovery 2008, 7, 738-745 10.1038/nrd2606
78. Scott, D. E.; Coyne, A. G.; Hudson, S. A.; Abell, C. Fragment-based approaches in drug discovery and chemical biology Biochemistry 2012, 51, 4990-5003 10.1021/bi3005126
79. Mittermaier, A. K.; Kay, L. E. Observing biological dynamics at atomic resolution using NMR Trends Biochem. Sci. 2009, 34, 601-611 10.1016/j.tibs.2009.07.004
80. Hajduk, P. J.; Huth, J. R.; Fesik, S. W. Druggability indices for protein targets derived from NMR-based screening data J. Med. Chem. 2005, 48, 2518-2525 10.1021/jm049131r
81. Watkins, A. M.; Arora, P. S. Anatomy of beta-strands at protein-protein interfaces ACS Chem. Biol. 2014, 9, 1747-1754 10.1021/cb500241y
82. Halgren, T. New method for fast and accurate binding-site identification and analysis Chem. Biol. Drug Des. 2007, 69, 146-148 10.1111/j.1747-0285.2007.00483.x
83. Marsh, E. N. G.; Suzuki, Y. Using F-19 NMR to probe biological interactions of proteins and peptides ACS Chem. Biol. 2014, 9, 1242-1250 10.1021/cb500111u
84. Hoeltzli, S. D.; Frieden, C. F-19 NMR spectroscopy of 6-F-19 tryptophan-labeled Eschericia-coli dihydrofolate reductase-equilibrium folding and ligand-binding studies Biochemistry 1994, 33, 5502-5509 10.1021/bi00184a019
85. Luck, L. A.; Falke, J. J. F-19 NMR-studies of the D-galactose chemosensory receptor. 1. sugar binding yields a global structural change Biochemistry 1991, 30, 4248-4256 10.1021/bi00231a021
86. Luck, L. A.; Falke, J. J. Open conformation of a substrate-binding cleft F-19 NMR studies of cleft angle in the D-galactose chemosensory receptor Biochemistry 1991, 30, 6484-6490 10.1021/bi00240a019
87. Danielson, M. A.; Biemann, H. P.; Koshland, D. E.; Falke, J. J. Attract-induced and disulfide conformational-changes in the ligand-binding domain of the chemotaxis aspartate receptor-a F-19 NMR-Study Biochemistry 1994, 33, 6100-6109 10.1021/bi00186a009
88. Goto, N. K.; Zor, T.; Martinez-Yamout, M.; Dyson, H. J.; Wright, P. E. Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP)-The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain J. Biol. Chem. 2002, 277, 43168-43174 10.1074/jbc.M207660200
89. Seyedsayamdost, M. R.; Reece, S. Y.; Nocera, D. G.; Stubbe, J. Mono-, di-, tri-, and tetra-substituted fluorotyrosines: New probes for enzymes that use tyrosyl radicals in catalysis J. Am. Chem. Soc. 2006, 128, 1569-1579 10.1021/ja055926r
90. Jordan, J. B.; Poppe, L.; Xia, X. Y.; Cheng, A. C.; Sun, Y.; Michelsen, K.; Eastwood, H.; Schnier, P. D.; Nixey, T.; Zhong, W. G. Fragment based drug discovery: practical implementation based on F-19 NMR Spectroscopy J. Med. Chem. 2012, 55, 678-687 10.1021/jm201441k
91. Yu, L. P.; Hajduk, P. J.; Mack, J.; Olejniczak, E. T. Structural studies of Bcl-xL/ligand complexes using F-19 NMR J. Biomol. NMR 2006, 34, 221-227 10.1007/s10858-006-0005-y
92. Yap, B. K.; Leung, E. W. W.; Yagi, H.; Galea, C. A.; Chhabra, S.; Chalmers, D. K.; Nicholson, S. E.; Thompson, P. E.; Norton, R. S. A potent cyclic peptide targeting SPSB2 protein as a potential anti-infective Agent J. Med. Chem. 2014, 57, 7006-7015 10.1021/jm500596j
93. Devine, S. M.; Mulcair, M. D.; Debono, C. O.; Leung, E. W. W.; Nissink, J. W. M.; Lim, S. S.; Chandrashekaran, I. R.; Vazirani, M.; Mohanty, B.; Simpson, J. S.; Baell, J. B.; Scammells, P. J.; Norton, R. S.; Scanlon, M. J. Promiscuous 2-aminothiazoles (PrATs): A frequent hitting scaffold J. Med. Chem. 2015, 58, 1205-1214 10.1021/jm501402x
94. Filippakopoulos, P.; Knapp, S. Targeting bromodomains: epigenetic readers of lysine acetylation Nat. Rev. Drug Discovery 2014, 13, 337-356 10.1038/nrd4286
95. Ember, S. W. J.; Zhu, J.-Y.; Olesen, S. H.; Martin, M. P.; Becker, A.; Berndt, N.; Georg, G. I.; Schoenbrunn, E. Acetyl-lysine binding site of bromodomain-containing protein 4 (BRD4) interacts with diverse kinase inhibitors ACS Chem. Biol. 2014, 9, 1160-1171 10.1021/cb500072z
96. Filippakopoulos, P.; Qi, J.; Picaud, S.; Shen, Y.; Smith, W. B.; Fedorov, O.; Morse, E. M.; Keates, T.; Hickman, T. T.; Felletar, I.; Philpott, M.; Munro, S.; McKeown, M. R.; Wang, Y. C.; Christie, A. L.; West, N.; Cameron, M. J.; Schwartz, B.; Heightman, T. D.; La Thangue, N.; French, C. A.; Wiest, O.; Kung, A. L.; Knapp, S.; Bradner, J. E. Selective inhibition of BET bromodomains Nature 2010, 468, 1067-1073 10.1038/nature09504
97. Martin, M. P.; Olesen, S. H.; Georg, G. I.; Schoenbrunn, E. Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl-lysine recognition site of bromodomains ACS Chem. Biol. 2013, 8, 2360-2365 10.1021/cb4003283
98. Chung, C. W.; Dean, A. W.; Woolven, J. M.; Bamborough, P. Fragment-based discovery of bromodomain inhibitors Part 1: Inhibitor binding modes and implications for lead discovery J. Med. Chem. 2012, 55, 576-586 10.1021/jm201320w
99. Williams, S. P.; Haggie, P. M.; Brindle, K. M. F-19 NMR measurements of the rotational mobility of proteins in vivo Biophys. J. 1997, 72, 490-498 10.1016/S0006-3495(97)78690-9
100. Takaoka, Y.; Kioi, Y.; Morito, A.; Otani, J.; Arita, K.; Ashihara, E.; Ariyoshi, M.; Tochio, H.; Shirakawa, M.; Hamachi, I. Quantitative comparison of protein dynamics in live cells and in vitro by in-cell F-19-NMR Chem. Commun. 2013, 49, 2801-2803 10.1039/c3cc39205h
101. Lee, Y.; Zeng, H. F.; Ruedisser, S.; Gossert, A. D.; Hilty, C. Nuclear magnetic resonance of hyperpolarized fluorine for characterization of protein-ligand interactions J. Am. Chem. Soc. 2012, 134, 17448-17451 10.1021/ja308437h
102. Feeney, J.; McCormick, J. E.; Bauer, C. J.; Birdsall, B.; Moody, C. M.; Starkmann, B. A.; Young, D. W.; Francis, P.; Havlin, R. H.; Arnold, W. D.; Oldfield, E. F-19 nuclear magnetic resonance chemical shifts of fluorine containing aliphatic amino acids in proteins: Studies on Lactobacillus casei dihydrofolate reductase containing (2S,4S)-5-fluoroleucine J. Am. Chem. Soc. 1996, 118, 8700-8706 10.1021/ja960465i
103. Eichler, J. F.; Cramer, J. C.; Kirk, K. L.; Bann, J. G. Biosynthetic incorporation of fluorohistidine into proteins in E-coli: A new probe of macromolecular structure ChemBioChem 2005, 6, 2170-2173 10.1002/cbic.200500249
104. Bann, J. G.; Pinkner, J.; Hultgren, S. J.; Frieden, C. Real-time and equilibrium F-19-NMR studies reveal the role of domain-domain interactions in the folding of the chaperone PapD Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 709-714 10.1073/pnas.022649599
105. Acchione, M.; Lee, Y. C.; DeSantis, M. E.; Lipschultz, C. A.; Wlodawer, A.; Li, M.; Shanmuganathan, A.; Walter, R. L.; Smith-Gill, S.; Barchi, J. J. Specific fluorine labeling of the HyHEL10 antibody affects antigen binding and dynamics Biochemistry 2012, 51, 6017-6027 10.1021/bi300455t
106. Arseniev, A. S.; Kuryatov, A. B.; Tsetlin, V. I.; Bystrov, V. F.; Ivanov, V. T.; Ovchinnikov, Y. A. F-19 NMR study of 5-fluorotryptophan-labeled bacteriorhodopsin FEBS Lett. 1987, 213, 283-288 10.1016/0014-5793(87)81506-5
107. Salopek-Sondi, B.; Vaughan, M. D.; Skeels, M. C.; Honek, J. F.; Luck, L. A. F-19 NMR studies of the leucine-isoleucine-valine binding protein: Evidence that a closed conformation exists in solution J. Biomol. Struct. Dyn. 2003, 21, 235-246 10.1080/07391102.2003.10506919
108. Falke, J. J.; Luck, L. A.; Scherrer, J. F-19 nuclear magnetic resonance studies of aqeuous and transmembrane receptors-examples from the Escherichia coli chemosensory pathway Biophys. J. 1992, 62, 82-86 10.1016/S0006-3495(92)81787-3
109. Boehm, J. C.; Bower, M. J.; Gallagher, T. F.; Kassis, S.; Johnson, S. R.; Adams, J. L. Phenoxypyrimidine inhibitors of p38 alpha kinase: Synthesis and statistical evaluation of the p38 inhibitory potencies of a series of 1-(piperidin-4-yl)-4-(4-fluorophenyl)-5-2-phenoxypyrimidin-4-yl) imidazoles Bioorg. Med. Chem. Lett. 2001, 11, 1123-1126 10.1016/S0960-894X(01)00163-9